Phase 1 Study of ADX-626 in Healthy Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This first-in-human study will evaluate the safety and tolerability of ADX-626 in healthy participants. The study will also look at how ADX-626 interacts with the human body (the pharmacokinetics and pharmacodynamics of ADX-626).
Epistemonikos ID: 67c4e7536857b5b5cb30585395604cc49a38bd21
First added on: Jul 24, 2025